Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • Log out
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Original Articles

Diabetic Nephropathy in Hypertransfused Patients With β-Thalassemia: The role of oxidative stress

  1. Ronen Loebstein, MD,
  2. Denis C Lehotay, PHD,
  3. Xiaoping Luo, MD,
  4. Wally Bartfay, MSC,
  5. Bev Tyler, BSCN and
  6. Graham D Sher, MD
  1. Division of Clinical Pharmacology and Toxicology, Department of Pediatrics and Research Institute, the Hospital for Sick Children Toronto, Ontario, Canada
  2. Division of Biochemistry, Department of Pediatrics and Research Institute, the Hospital for Sick Children Toronto, Ontario, Canada
  3. Division of Hematology/Oncology, the Toronto Hospital, the University of Toronto Toronto, Ontario, Canada
  1. Address correspondence and reprint requests to Dr. Graham D. Sher, MD, Blood Transfusion Service, the Toronto Hospital, 200 Elizabeth St., Toronto, Ontario M5G 2C4, Canada. E-mail: gsher{at}torhosp.toronto.on.ca
Diabetes Care 1998 Aug; 21(8): 1306-1309. https://doi.org/10.2337/diacare.21.8.1306
PreviousNext
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

OBJECTIVE Pathogenesis of diabetes-related microvascular complications involving oxidative damage by free radicals has been demonstrated. Free radical generation has been shown to derive largely from iron. Our objectives, therefore, were to determine if there is an increased incidence and/or an accelerated course of nephropathy in patients with diabetes, secondary to transfusional hemochromatosis, and to examine whether free radical activity contributes to the development of this complication.

RESEARCH DESIGN AND METHODS We evaluated nine patients with homozygous β-thalassemia, complicated by clinically overt diabetes, for diabetic nephropathy over a 7-year period. Lipid peroxidation was quantified by measuring the presence of 20 saturated and unsaturated aldehydes, and results were compared with five normotensive type 1 diabetic patients without iron overload.

RESULTS Nephropathy developed in five of nine patients (55%) after a mean duration of overt diabetes of 3.6 ± 2.0 years. Three patients showed evidence of progressive microalbuminuria over a 7-year period (24.7–46.2, 52.2–430.1, and 17.7–54.3 μg/min, respectively). Two patients with borderline microalbuminuria (19.9 and 14.5 μg/min, respectively) demonstrated stable albumin excretion rates over the follow-up period. Total aldehyde concentration was significantly higher in β-thalassemia diabetic patients, compared with nonthalassemic diabetic control subjects (8,106 ± 1,280 vs. 4,594 ± 247 nmol/l; P < 0.0001). The three patients with progressive microalbuminuria demonstrated significantly higher total aldehyde concentration, compared with the other β-thalassemia diabetic patients with stable albumin excretion (9,428 ± 337 vs. 7,445 ± 1,003 nmol/l; P < 0.01). Serum vitamin E concentrations were significantly lower in β-thalassemia patients with diabetes, compared with diabetic patients without iron overload (12.1 ± 6.0 vs. 25.9 ± 11.4 μ/l; P = 0.02). Serum vitamin C concentrations did not differ between the two groups. Multiple regression analysis demonstrated total aldehyde concentration to be the most significant predictor for the development of microalbuminuria (P = 0.01), followed by the duration of diabetes (P = 0.02) and glycemic control (P = 0.02).

CONCLUSIONS Early development and an accelerated course of diabetic nephropathy in iron-loaded patients with β-thalassemia are observed. These findings may be attributed to high oxidative stress in these patients, which is secondary to iron-derived free radicals and to the patients' diminished antioxidant reserves.

  • Received December 2, 1997.
  • Accepted April 14, 1998.
  • Copyright © 1998 by the American Diabetes Association
PreviousNext
Back to top

In this Issue

August 1998, 21(8)
  • Table of Contents
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Diabetic Nephropathy in Hypertransfused Patients With β-Thalassemia: The role of oxidative stress
(Your Name) has forwarded a page to you from Diabetes Care
(Your Name) thought you would like to see this page from the Diabetes Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Diabetic Nephropathy in Hypertransfused Patients With β-Thalassemia: The role of oxidative stress
Ronen Loebstein, Denis C Lehotay, Xiaoping Luo, Wally Bartfay, Bev Tyler, Graham D Sher
Diabetes Care Aug 1998, 21 (8) 1306-1309; DOI: 10.2337/diacare.21.8.1306

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Diabetic Nephropathy in Hypertransfused Patients With β-Thalassemia: The role of oxidative stress
Ronen Loebstein, Denis C Lehotay, Xiaoping Luo, Wally Bartfay, Bev Tyler, Graham D Sher
Diabetes Care Aug 1998, 21 (8) 1306-1309; DOI: 10.2337/diacare.21.8.1306
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

Original Articles

  • Obstetric Management in Gestational Diabetes
  • Prevention of Type 2 Diabetes in Women With Previous Gestational Diabetes
  • Cellular Mechanisms for Insulin Resistance in Normal Pregnancy and Gestational Diabetes
Show more Original Articles

Pathophysiology/Complications

  • Impact of Type 1 Diabetes in the Developing Brain in Children: A Longitudinal Study
  • Obstructive Sleep Apnea, Glucose Tolerance, and β-Cell Function in Adults With Prediabetes or Untreated Type 2 Diabetes in the Restoring Insulin Secretion (RISE) Study
  • Importance of Intestinal Environment and Cellular Plasticity of Islets in the Development of Postpancreatectomy Diabetes
Show more Pathophysiology/Complications

Similar Articles

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.